Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors

Journal of Acquired Immune Deficiency Syndromes

Volumn 29, Issue 5, 2002, Pages 429-434

  Plana, Montserrat ^a   Martínez, Catalina ^a   García, Felipe ^a   Maleno, María J ^a   Barceló, Juan J ^a   García, Ana ^a   Lejeune, Marylène ^a   Vidal, Carmen ^a   Cruceta, Anna ^a   Miró, José M ^a   Pumarola, Tomás ^a   Gallart, Teresa ^a   Gatell, José M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic HIV 1 infection; Immune reconstitution; Nonnucleoside reverse transcriptase inhibitors; Protease inhibitors; T cell functions; T cell subsets

Indexed keywords

CD38 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; HLA DR ANTIGEN; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TETANUS TOXOID; VIRUS ANTIGEN;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE FUNCTION; LYMPHOID TISSUE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

EID: 0036238928     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200204150-00001     Document Type: Article

References (16)

1. Toward an understanding of the correlates of protective immunity to HIV infection
2. Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type-1 infected persons
3. Antiretroviral therapy in adults: Updated recommendation of the International AIDS Society-USA panel
4. Comparison of immunologic restoration and virological response in plasma, tonsillar tissue and cerebrospinal fluid in HIV-1 infected patients treated with double versus triple antiretroviral therapy in very early stages. The Spanish Earth-2 Study
5. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: The Spanish Earth-1 study
6. An open randomized study comparing d4T plus ddl and nevirapine (QD) vs d4T plus ddI and nevirapine (BID) in antiretroviral-naive chronic HIV-1-infected patients in very early stages (Spanish SCAN Study)
7. Effects of antiretroviral therapy on immune reconstitution
8. Immunologic benefits of antiretroviral therapy In very early stages of asymptomatic chronic HIV-1 infection
9. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
10. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial. Italy, The Netherlands, Canada and Australia Study
11. Detection of low HIV-1 RNA levels in plasma
12. Lack of T-cell proliferative response to HIV-1 antigens after one year of HAART in very early HIV-1 disease
13. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
14. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200/ml or less
15. Preliminary results of a randomized multicenter study comparing combivir (ZDV/3TC) plus nelfinavir or nevirapine in HIV-infected naive patients (COMBINE Study)
16. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression